U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca

The United States has put Johnson and Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and has stopped British drugmaker AstraZeneca Plc from using the facility, a senior health official said on Saturday.

Reuters | Updated: 05-04-2021 08:33 IST | Created: 05-04-2021 08:33 IST
U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca

The United States has put Johnson and Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and has stopped British drugmaker AstraZeneca Plc from using the facility, a senior health official said on Saturday. J&J said it was "assuming full responsibility" of the Emergent BioSolutions facility in Baltimore, reiterating that it will deliver 100 million doses to the government by the end of May.

In a separate statement late Sunday, Emergent said it expects to align with the U.S. government and AstraZeneca to ramp down manufacturing for AstraZeneca’s COVID-19 vaccine at its Baltimore plant. The Department of Health and Human Services has also increased Emergent's order by $23 million for expansion of production specific to J&J's vaccine doses, Emergent added.

"The $23 million will be used for the purchase of biologics manufacturing equipment specific to Johnson & Johnson’s COVID-19 vaccine for the potential expansion of manufacturing of that bulk drug substance into a third suite of Emergent’s Baltimore Bayview facility," the company said. The Department of Health and Human Services facilitated the move, the health official said in an email, asking not to be named due to the sensitivity of the matter.

AstraZeneca, whose vaccine has not been approved in the United States, said it will work with President Joe Biden's administration to find an alternative site to produce its vaccine. White House officials did not immediately respond to a request for comment.

The development, first reported by the New York Times, further hampers AstraZeneca's efforts in the United States. The government has criticized the drugmaker for using outdated data in the results of its vaccine trial. It later revised its study. Workers at the Emergent BioSolutions plant several weeks ago conflated ingredients for the J&J and AstraZeneca vaccines, the Times said earlier in the week. J&J said at the time the ruined batch had not advanced to the fill-and-finish stage.

The government's move to have the facility make only the J&J single-dose vaccine is meant to avoid future mix-ups, the Times said, citing two senior federal health officials. The top U.S. infectious disease doctor told Reuters on Thursday the country may not need AstraZeneca's vaccine even if it wins approval.

The United States has loan deals to send Mexico and Canada roughly 4 million doses of the AstraZeneca vaccine, made at its U.S. facility.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Soccer-Crunch time has arrived in United's bid to challenge City

The protests from fans have grabbed the headlines but if Manchester United want to really challenge their neighbours Manchester City for the title in the coming seasons, they will need to get their focus quickly back on to the field.On Tues...

Vaccine paucity: Maha suspends vaccination for 18-44 age group

Due to the acute shortage of COVID-19 vaccines in Maharashtra, the state government on Wednesday decided to temporarily suspend its drive to vaccinate people in the age group of 18 to 44 and divert the available stock of doses for the above...

India may overtake China as most populous country sooner than UN projections of 2027: Report

Chinese demographers say India will become the worlds most populous country earlier than the United Nations projection of 2027, surpassing China where a steady drop in the birth rate has been recorded in the last few years. India is expecte...

COVID-19 infections surge among prisoners in Bangkok

Nearly 3,000 inmates at two prisons in Thailands capital have tested positive for COVID-19, the Corrections Department said Wednesday, as the country battles a new wave of the coronavirus.The department said 1,785 of the 3,274 inmates teste...

Give Feedback